Perspectives for effective cancer drug development: The EORTC SPECTA Initiative

Bookmark and Share
Published: 26 Jun 2014
Views: 2461
Dr Denis Lacombe - EORTC, Brussels, Belgium

Dr Lacombe, director of the European Organisation for Research and Treatment of Cancer, talks to ecancertv about the SPECTA (Screening Patients for Efficient Clinical Trial Access) initiative at WIN 2014.